Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm, Safety and Efficacy Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

NCT06008678 is registered in ClinicalTrials.gov with Resvent Holding USA LTD as lead sponsor.

NCT NCT06008678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm, Safety and Efficacy Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea
Lead sponsor
Resvent Holding USA LTD
Phase
Not applicable
Overall status
Completed
Start date
August 22, 2023
Completion date
November 29, 2023
Enrollment
146 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea